NAGA-TCF20 Fusion FISH Probe
The NAGA-TCF20 Fusion FISH Probe is used to confirm a fusion of the NAGA and TCF20 genes. The fusion of the NAGA and TCF20 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NAGA-TCF20-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NAGA-TCF20-20-AQAQ | 20 (40 μL) | 200 μL |
|
NAGA Gene Summary
NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease). [provided by RefSeq, Jul 2008]
Gene Name: Alpha-N-acetylgalactosaminidase
Chromosome: CHR22: 42454337 -42466846
Locus: 22q13.2
TCF20 Gene Summary
This gene encodes a transcription factor that recognizes the platelet-derived growth factor-responsive element in the matrix metalloproteinase 3 promoter. The encoded protein is thought to be a transcriptional coactivator, enhancing the activity of transcription factors such as JUN and SP1. Mutations in this gene are associated with autism spectrum disorders. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
Gene Name: Transcription Factor 20
Chromosome: CHR22: 42556018 -42611445
Locus: 22q13.3
Gene Diseases
The NAGA TCF20 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|